L&C BIO Co.,LTD (KOSDAQ:290650)
62,600
-2,200 (-3.40%)
May 20, 2026, 3:30 PM KST
179.46% (1Y)
| Market Cap | 1.56T +228.1% |
| Revenue (ttm) | 85.48B +18.7% |
| Net Income | -138.17B |
| EPS | -5,819.37 |
| Shares Out | 24.85M |
| PE Ratio | n/a |
| Forward PE | 57.30 |
| Dividend | 50.00 (0.08%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 185,099 |
| Average Volume | 308,519 |
| Open | 64,400 |
| Previous Close | 64,800 |
| Day's Range | 60,000 - 64,400 |
| 52-Week Range | 21,800 - 125,000 |
| Beta | 1.34 |
| RSI | 44.29 |
| Earnings Date | Mar 24, 2026 |